 |
|
Updated Recommendations on the Use of Pneumococcal Conjugate Vaccine in a Setting of Vaccine Shortage—Advisory Committee on Immunization Practices
JAMA. 2002;287:833-834.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
MMWR. 2001;50:1140-1142
In September 2000, CDC published an interim vaccination schedule recommended by the Advisory Committee on Immunization Practices (ACIP) to be used during a pneumococcal conjugate vaccine shortage that was anticipated to be brief.1,2 Because the duration of the shortage has been longer and the severity has been greater than anticipated, ACIP has revised these recommendations to health-care providers who had been advised to conserve vaccine by decreasing the number of doses administered to healthy infants rather than to leave some infants unvaccinated. For infants who receive their first dose before age 6 months, vaccination with a maximum of 3 doses is recommended; the fourth dose should be deferred. All health-care providers should reduce the number of vaccine doses used and ordered, regardless of their current supply, so that vaccine is more widely available until supplies are adequate.
Because of greater-than-expected demand, vaccine has been back ordered for the . . . [Full Text of this Article]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Bacterial Colonization During Acute Otitis Media
Revai et al.
Pediatrics 2006;117:1823-1829.
ABSTRACT
| FULL TEXT
The Decline in Invasive Pneumococcal Disease
Pelton
Pediatrics 2004;113:617-618.
FULL TEXT
One-Year Uptake of Pneumococcal Conjugate Vaccine: A National Survey of Family Physicians and Pediatricians
Davis et al.
J Am Board Fam Med 2003;16:363-371.
ABSTRACT
| FULL TEXT
|
